About SYNLICO INC
Synlico Inc. is a company focused on AI-driven drug discovery, integrating artificial intelligence, single-cell bioinformatics, and causal cell modeling to develop potent therapies for various diseases by identifying causal links between cellular activities and patient responses.
AI-driven drug discoverySingle-cell bioinformaticsCausal cell modelingComputational platform for identifying causal effects of gene interventionsPrediction-based AI platform for patient microenvironment responses
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SYNLICO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.